Drug Shortage Report for AURO-SILODOSIN

Last updated on 2024-04-16 History
Report ID 207409
Drug Identification Number 02478501
Brand name AURO-SILODOSIN
Common or Proper name AURO-SILODOSIN
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) SILODOSIN
Strength(s) 4MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30's
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-10-19
Actual start date 2023-10-23
Estimated end date 2024-05-01
Actual end date
Shortage status Actual shortage
Updated date 2024-04-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-04-16 French Compare
v12 2024-04-16 English Compare
v11 2024-04-05 French Compare
v10 2024-04-05 English Compare
v9 2024-03-13 French Compare
v8 2024-03-13 English Compare
v7 2024-02-26 French Compare
v6 2024-02-26 English Compare
v5 2023-12-28 French Compare
v4 2023-12-28 English Compare
v3 2023-10-24 English Compare
v2 2023-10-19 French Compare
v1 2023-10-19 English Compare

Showing 1 to 13 of 13